Skip to main content
. 2022 Oct 28;13:20406207221132346. doi: 10.1177/20406207221132346

Figure 6.

Figure 6.

Clinical features of new risk stratification based on ICAM2 status. (a) Heatmap of clinical characteristics (sex, age, white blood cell count, ELN-2017 risk, gene fusion, NPM1, FLT3-ITD, and transplant) between favorable_new and adverse_new. (b) LSC17 score predicted the overall survival rate of AML. (c) The adverse_new group had a higher LSC17 score, but only a lower accuracy in predicting the outcome (AUC = 0.637). (d) In the adverse_new group, several LSC-related genes were up-regulated.